Jvion, a leader in prescriptive clinical artificial intelligence (AI), announced their predictions for healthcare in 2021. As the outcome of the 2020 election comes into focus and the pandemic surges to its most severe stage yet, both factors will weigh heavily on the direction of healthcare in the year to come.
“With the election decided, it’s clear that health system revenue will continue to shift to value-based care models,” said Dr. John Showalter, Jvion’s Chief Product Officer. “Once it reaches a tipping point of 50% of total revenue, providers’ financial performance will be inextricably linked to their patients’ outcomes.”
“To survive, providers and payers will need to harness their data to predict and mitigate patient risk, and prescriptive clinical AI will be an essential capability,” adds Dr. John Frownfelter, Jvion’s Chief Medical Information Officer. “And with a new surge in Covid-19 extending the toll on health systems through at least early 2022, clinical AI will be more essential than ever to prevent negative quality events and keep costs down.”